MENLO PARK, Calif. and MADISON, Wis., May 23, 2024 - Gamma Biosciences, a life sciences platform established by KKR to address the advanced therapy bioprocessing market, today announced that it.
Investment funds managed by KKR, a leading global investment firm, have agreed to acquire Immedica Pharma, a pharmaceutical company headquartered in Stockholm, Sweden, focused on the.
Coriolis Pharma secures investment from KKR to support next steps in growth and to expand global footprintNewly formed KKR platform Frontier Biosolutions and its globally renowned experts will serve as advisors to Coriolis PharmaMARTINSRIED-MUNICH, Germany, October 16, 2023 / B3C newswire / Coriolis Pharma, a glo.
KKR and Flerie to support organic and inorganic growth to extend Coriolis’ leadership position in formulation development and analytical services for innovative high-value biologics and cell and.